Severe Congenital Neutropenia due to JAGN1 Deficiency: A Patient Guide
At a Glance
JAGN1-related severe congenital neutropenia is a rare inherited disorder that reduces infection-fighting white blood cells and their function. Care focuses on prompt infection evaluation, dental protection, G-CSF treatment, and specialist monitoring; a bone marrow transplant may help some children.
Severe congenital neutropenia (SCN) due to JAGN1 deficiency is an exceptionally rare genetic condition that affects how the body produces and uses neutrophils, the white blood cells responsible for being the first responders to bacterial and fungal infections. In children with this diagnosis, the “factory” in the bone marrow faces a biological hurdle: it struggles to mature these cells, and the few that do reach the bloodstream often lack the necessary tools to fight germs effectively. Because this is an autosomal recessive condition, it is usually inherited from two healthy parents who each carry one copy of the changed gene, often without any prior family history of the disease [1][2]. Genetic counseling can help families understand carrier testing, recurrence risk, and options for siblings or future pregnancies.
Living with JAGN1-SCN means remaining vigilant against infections that can become serious very quickly. While many children experience frequent skin abscesses or respiratory issues, the condition also specifically affects the mouth and gums, leading to severe dental disease that requires early and aggressive intervention. Some children may also experience “syndromic” features, such as slower physical growth or developmental delays, which are often linked to specific variations in the JAGN1 gene. Understanding these diverse symptoms helps a care team tailor monitoring to each child’s unique needs [3][4].
The pillars of managing this condition focus on boosting the immune system and guarding against long-term risks. Most children receive daily injections of a medicine called G-CSF to help the bone marrow produce more neutrophils, though JAGN1 patients often require higher amounts of this medicine than those with other forms of neutropenia. For children whose condition does not respond well to medicine or who face life-threatening complications, a bone marrow transplant offers a potential correction for the blood-related symptoms. Throughout this journey, regular bone marrow check-ups are essential to ensure the “factory” remains healthy and to catch any cellular changes as early as possible [5][6].
While a diagnosis of JAGN1-SCN brings significant changes to daily life, it also brings a clear path for specialized care. Modern medicine provides the tools to manage infections, protect dental health, and monitor long-term safety with precision. By working closely with a team of experts—including hematologists, immunologists, and specialized dentists—parents can provide their children with the protection they need while focusing on the joy of their growth and development through childhood and into adulthood [7][8].
In this guide
6 chapters
Understanding JAGN1 Severe Congenital Neutropenia
Learn what JAGN1 severe congenital neutropenia means, why fever is urgent, and how G-CSF, dental care, monitoring, and transplant planning support care.
The Biology and Symptoms of JAGN1 Deficiency
Learn how JAGN1 deficiency causes severe congenital neutropenia, including frequent infections, mouth and dental problems, and variant-related growth concerns.
Navigating the Diagnosis and Pathology Reports
Learn how JAGN1 severe congenital neutropenia is diagnosed through genetic testing, bone marrow findings, ANC results, and baseline CSF3R and RUNX1 testing.
Daily Management and Standard of Care Treatment
Learn daily management of JAGN1 severe congenital neutropenia, including G-CSF, infection prevention, dental care, fever planning, and long-term monitoring.
Considering a Bone Marrow Transplant for JAGN1
Learn when bone marrow transplant is considered for JAGN1 severe congenital neutropenia, including G-CSF response, major risks, and autologous reconstitution.
Long-Term Monitoring and Bone Marrow Health
Learn how JAGN1 severe congenital neutropenia is monitored over time, including annual bone marrow exams, mutation testing, blood counts, growth, and bone health
Common questions in this guide
How does JAGN1 deficiency lead to severe congenital neutropenia?
What health problems can children with JAGN1-SCN develop?
How does G-CSF treatment help a child with JAGN1-SCN?
When might a bone marrow transplant be considered?
Why is dental care especially important in JAGN1-SCN?
What should families do if a child with JAGN1-SCN develops a fever?
Get notified when new evidence is published on Severe congenital neutropenia due to JAGN1 deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia.
Farmand S, Aydin SE, Wustrau K, et al.
Frontiers in immunology 2024; (15()):1373495 doi:10.3389/fimmu.2024.1373495.
PMID: 39286252 - 2
Jagunal homolog 1 safeguards neutrophil immune function by preserving protein sialylation during differentiation.
Nussbaumer K, Hübner M, da Costa R, et al.
Blood advances 2026; (10(21)):7311-7324 doi:10.1182/bloodadvances.2026019794.
PMID: 42685351 - 3
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP.
Fekadu-Siebald J, Salzmann-Manrique E, Heusel JR, et al.
Blood advances 2025; (9(7)):1702-1711 doi:10.1182/bloodadvances.2024014344.
PMID: 39775668 - 4
Chronic neutropenia: how best to assess severity and approach management?
Donadieu J, Frenz S, Merz L, et al.
Expert review of hematology 2021; (14(10)):945-960 doi:10.1080/17474086.2021.1976634.
PMID: 34486458 - 5
Severe congenital neutropenias.
Skokowa J, Dale DC, Touw IP, et al.
Nature reviews. Disease primers 2017; (3()):17032 doi:10.1038/nrdp.2017.32.
PMID: 28593997 - 6
HSCT may lower leukemia risk in ELANE neutropenia: a before-after study from the French Severe Congenital Neutropenia Registry.
Rotulo GA, Beaupain B, Rialland F, et al.
Bone marrow transplantation 2020; (55(8)):1614-1622 doi:10.1038/s41409-020-0800-1.
PMID: 31992846 - 7
Family Knowledge, Attitudes, and Practices Toward Severe Congenital Neutropenia.
Karadaş N, Yilmaz Y, Önen Göktepe Ş, et al.
Journal of pediatric hematology/oncology 2023; (45(4)):e441-e445 doi:10.1097/MPH.0000000000002634.
PMID: 36897312 - 8
Manifestation of severe congenital neutropenia in the oral cavity. Case report.
Krasuska-Sławińska E, Klaudel-Dreszler M, Minota M, et al.
Central-European journal of immunology 2013; (48(1)):70-74 doi:10.5114/ceji.2023.125312.
PMID: 37206584
This page is for informational purposes only and does not constitute medical advice about your child’s JAGN1-related neutropenia. Your child’s hematology, immunology, genetics, and dental teams should tailor infection plans, treatment, and monitoring.